Pharmacogenomic testing: the cost factor

Pharmacogenomics J. 2001;1(3):171-4. doi: 10.1038/sj.tpj.6500033.
No abstract available

Publication types

  • Review

MeSH terms

  • Cost-Benefit Analysis / economics
  • Costs and Cost Analysis / economics
  • Costs and Cost Analysis / methods
  • Genotype
  • Humans
  • Patient Selection
  • Pharmacogenetics / economics*